We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
TRULICITY dulaglutide 1.5 mg/0.5 mL solution for injection prefilled pen (Netherlands)
Section 19A approved medicine
TRULICITY dulaglutide 1.5 mg/0.5 mL solution for injection prefilled pen (Netherlands)
Section 19A approval holder
Medsurge Healthcare Pty Ltd ABN 92 124 728 892
Phone
1300 788 261
Approved until
Status
Current
Medicines in short supply/unavailable
TRULICITY dulaglutide (rch) 1.5 mg/0.5 mL solution for injection prefilled pen - AUST R: 217965
Indication(s)
Type 2 Diabetes Mellitus - Trulicity is indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise
- as monotherapy when metformin is considered inappropriate due to intolerance or contraindications
- in addition to other medicinal products for the treatment of diabetes.
Images
